Tecan, Waters and Inpeco are among a group of investors that have invested $14m in robotics company Andrew Alliance.

GV and Time Warner Investments have both returned for the series C round and were joined by new corporate investors Hearst Ventures.

Johnson & Johnson, Intermountain Healthcare and Nvidia have backed a $30m series C round for Zebra Medical Vision.

Pivotal BioVenture Partners and Roche have both returned to back a series C round for SutroVax, which has also added TPG, Medicxi and Foresite Capital to its shareholders.

The round was already the largest ever at the previously reported $10bn mark but has been revealed to stand even taller with an additional $4bn.

Lilly Asia Ventures and existing investor Alexandria Venture Investments have taken part in a $65m series C round for metabolic disease treatment developer Metacrine.

The round, already backed by Amazon Alexa Fund, has been increased by $36m through an extension that featured AGL Energy.

Northwestern Mutual Future Ventures backed a $70m series C round for Chime, having previously supported an $18m series B nine months ago.

GV is reportedly leading a funding round for Lime, a bike-sharing platform also backed by NGP Capital and the Stanford-StartX fund.